The state of an increasing prostate-specific antigen level after radical prostatectomy (RP) or radiation therapy (RT) for localized prostate cancer (PCa) is known as biochemical recurrence (BCR) or biochemical relapse. The gene discussed is KLK3; the disease is posterior cortical atrophy.